Sleep and circadian disruptors: Unhealthy noise and light levels for hospitalized pediatric patients.
Andrea L Fidler, Julie Waitt, Leslie E Lehmann...
https://pubmed.ncbi.nlm.nih.gov/37779507Actively Recruiting
Phase Not Applicable
Age: 9Years - 17Years
All Genders
ID06468618
Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients
Led by Dana-Farber Cancer Institute · Updated on 2025-07-15
10
Participants Needed
2
Research Sites
8 weeks
Total Duration
On this page
Sponsors
D
Dana-Farber Cancer Institute
Lead Sponsor
A
American Cancer Society, Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are studying pediatric patients aged 9 to 17 who are undergoing stem cell transplants and often face sleep disturbances during their long hospital stays. This study evaluates the acceptability and feasibility of the DREAMS program, which aims to support sleep and circadian health in these children. The research is funded by the American Cancer Society and conducted by Dana-Farber Cancer Institute at Boston Children's Hospital. The DREAMS program includes an introductory video and a Sleep and Circadian Care Kit with tools such as ear plugs, a white noise machine, an eye mask, and a lightbox. Participants and their families will also receive an actigraph, Fitbit, and tablet to monitor sleep and activity. The study follows a single-arm pilot design where enrolled children receive the standard stem cell transplant care plus the DREAMS intervention. During the approximately two-week study, participants and their parents will complete baseline and follow-up surveys, use the provided sleep and circadian tools, and keep a daily sleep diary for one week. Researchers will measure enrollment rates, program acceptability, kit usage, and sleep disturbance using questionnaires. The study also monitors patient-reported outcomes and program experience to assess feasibility and inform future research.
CONDITIONS
Brief Title
Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients
Who Can Participate
Age: 9Years - 17Years
All Genders
Eligibility Criteria
You may qualify if you...
- Patient aged 9-17 years.
- Patient scheduled to receive a stem cell transplant at Boston Children's Hospital.
- English speaking child and primary caregiver (parent/guardian).
You will not qualify if you...
- Primary team declines permission to approach.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - About 2 weeks
Participants receive the DREAMS Program, including an introductory video and a Sleep and Circadian Care Kit with tools to support sleep and circadian health during stem cell transplant recovery.
1 baseline visit and 1 in-clinic visit to introduce the program
Follow-up
Duration - Up to 1 week after treatment (up to Day 28)
Participants complete follow-up surveys and assessments to evaluate the acceptability and usage of the DREAMS Program and related sleep outcomes.
1 follow-up visit (in-person or virtual)
Trial Site Locations
Total: 2 locations
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02215
Actively Recruiting
2
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02215
Actively Recruiting
Loading map...
Research Team
L
Lucille Lokko, BA
E
Eric Zhou, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here